Serial #98125296
LIVE

Serial Number

98125296

Owner

PHARMALYTICA INC.

Attorney

Pamela N. Hirschman

Filing Date

Aug 9, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98125296 Trademark

Serial Number: 98125296 • Registration: 8113222

Serial #98125296 is a trademark filed by PHARMALYTICA INC. on August 9, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

PHARMALYTICA INC. (2 trademarks)

PO BOX 84210 MARKET MALL
CALGARY, ALBERTA T3A5C4 , CA

Entity Type: 99

Okaki Health Intelligence Inc. (9 trademarks)

PO Box 84210 Market Mall
Calgary, Alberta T3A5C4 , CA

Entity Type: 99

Trademark Details

Filing Date

August 9, 2023

Registration Date

January 27, 2026

Published for Opposition

December 9, 2025

Goods & Services

Software as a service (SaaS) services featuring software in the fields of healthcare, and pharmacy services, namely, software as a service (SaaS) services featuring software for collecting, organizing, tracking, and analyzing pharmaceutical prescription and dispensation information and pharmacy clinical service information, software as a service (SaaS) services featuring software for accessing, querying and analyzing pharmacy prescription, dispensation, and clinical service information stored in databases and data warehouses, software as a service (SaaS) services featuring software to design and monitor medication treatment plans, track patient services, medication utilization, medication care gaps, medication adherence, and treatment outcomes of prescription medication, software as a service (SaaS) services featuring software for analyzing and optimizing medication treatment plans and monitoring medication utilization, medication care gaps, and medication adherence for chronic conditions, software as a service (SaaS) services featuring software for analyzing patient medications to improve patient safety and reduce medication-related risks, software as a service (SaaS) services featuring software for analyzing prescription, dispensation, and inventory flows of controlled medications for risk management and regulatory compliance purposes, software as a service (SaaS) services featuring software to optimize pharmacy clinical services and patient care through analysis of clinical service, prescription and dispensation information, and the generation of reports to support care planning, software as a service (SaaS) services featuring software to optimize clinical care and workflows through integration with pharmacy information systems; Providing temporary use of on-line non-downloadable web application software in the fields of healthcare and pharmacy services, namely, providing temporary use of on-line non-downloadable web application software for collecting, organizing, tracking, and analyzing pharmaceutical prescription and dispensation information, and pharmacy clinical service information; Providing temporary use of on-line non-downloadable web application software for accessing, querying and analyzing pharmacy prescription, dispensation, and clinical service information stored in databases and data warehouses; Providing temporary use of on-line non-downloadable web application software to design and monitor medication treatment plans, track patient services, medication utilization, medication care gaps, medication adherence, and treatment outcomes of prescription medication; Providing temporary use of on-line non-downloadable web application software for analyzing and optimizing medication treatment plans and monitoring medication utilization, medication care gaps, and medication adherence for chronic conditions; Providing temporary use of on-line non-downloadable web application software for analyzing patient medications to improve patient safety and reduce medication-related risks; Providing temporary use of on-line non-downloadable web application software for analyzing prescription, dispensation, and inventory flows of controlled medications for risk management and regulatory compliance; Providing temporary use of on-line non-downloadable web application software to optimize pharmacy clinical services and patient care through analysis of clinical service, prescription and dispensation information, and the generation of reports to support care planning; Providing temporary use of on-line non-downloadable web application software to optimize clinical care and workflows through integration with pharmacy information systems

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 27, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 27, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 30, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 31, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 31, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jul 31, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 31, 2025 TEME
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 31, 2025 CHAN
ASSIGNED TO LIE
Jul 31, 2025 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 22, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Apr 23, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Apr 23, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Apr 23, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 6, 2025 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 17, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 17, 2024 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 21, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 21, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jun 21, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 24, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 17, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 17, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 17, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 9, 2024 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 10, 2024 ASGN
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 12, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 10, 2023 NWOS
NEW APPLICATION ENTERED
Aug 12, 2023 NWAP